Growing Market Focus Dyad's strategic shift to commercial applications in life sciences, food, nutrition, and industrial biotech opens up diverse sales opportunities across sectors that require high-value proteins and enzymes, catering to companies seeking scalable, animal-free biological solutions.

Technological Leadership With proprietary gene expression platforms and advanced recombinant protein development, Dyad is well-positioned to partner with biotech firms, research institutions, and industrial manufacturers looking for innovative, high-quality bioproducts for their product pipelines.

Financial Stability The company's recent cash position of over 10 million dollars and active progress towards commercialization suggest a financially stable partner, making Dyad an appealing collaborator or supplier for customers prioritizing reliable supply chains.

Expanding Customer Base Recent milestone achievements with partners in life sciences and food sectors indicates an expanding portfolio of commercial clients, providing potential for cross-sell and deeper engagement with companies aiming to innovate with precision-engineered biotech products.

Event Presence Dyad’s active participation in investor conferences and industry events signifies its efforts to connect with potential clients and partners in biotech, life sciences, and industrial sectors, creating opportunities for direct outreach and strategic alliances.